Antimicrobial Peptide Capture Species for Multiplexed Biological Target Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Antibody-based detection systems face challenges such as sensitivity to environmental conditions, complexity in multiplexed assays, mutual exclusivity of specificity and sensitivity, unavailability of target-specific antibodies, and logistical burdens for long-term stability, limiting their use in field applications and multiplexed screenings.
Innovation Solution
Employing antimicrobial peptides and antibiotics as capture species in detection systems, which exhibit stability, semi-selective binding, and overlapping specificities, allowing for the use of pattern recognition algorithms to identify biological targets, and can be used in various detection platforms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If antibody-based detection systems are used for specific recognition of target analytes, then detection specificity is improved, but storage stability deteriorates requiring frozen or refrigerated conditions
Solution Approach 1:
The patent changes the fundamental parameter of the recognition molecule from antibody to antimicrobial peptide or antibiotic. This parameter change transforms the system from requiring cold chain storage to being stable at room temperature, while maintaining detection capability through the semi-selective binding properties of these peptides and antibiotics to microbial cell membranes
Solution Approach 2:
The patent employs antimicrobial peptides and antibiotics that are inherently stable and do not require refrigeration, effectively replacing the 'short-living' antibody molecules that need continuous cold storage. These peptides can be stored indefinitely at room temperature, eliminating the logistical burden of cold chain maintenance
2Adaptability or versatility
If multiple antibodies are used for each target in multiplexed assays, then detection capability for multiple targets is improved, but assay complexity increases
Solution Approach 1:
The patent applies universality by using antimicrobial peptides and antibiotics that can recognize multiple microbial species through semi-selective binding to invariant cell surface components. A single peptide or antibiotic can detect multiple targets, eliminating the need for one antibody per target and significantly reducing assay complexity in multiplexed applications
Solution Approach 2:
The patent segments the recognition function into semi-selective binding units (peptides/antibiotics) that target invariant microbial components rather than specific variable antigens. This segmentation allows a limited set of peptides to collectively detect a broad range of microbial targets through pattern recognition algorithms
3Measurement precision
If target-specific antibodies are developed for each analyte, then detection specificity is improved, but development time and cost increase
Solution Approach 1:
The patent employs antimicrobial peptides and antibiotics that naturally exhibit semi-selective binding to multiple microbial species through their invariant cell surface components. This universality eliminates the need for time-consuming development of separate antibodies for each target, as a single peptide can be used to detect multiple different microbial analytes
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the detection of multiple targets with fewer recognition molecules, improves storage characteristics, and reduces complexity, providing superior stability and sensitivity compared to traditional antibody-based methods, suitable for field applications and multiplexed assays.
Implementation Method 1
providing plurality of capture species bound to one or more substrates suspected of having one or more biological targets affinity bound to at least one capture species
Data Source
AI summary
A method of biochemical identification by: providing a plurality of capture species bound to one or more substrates and suspected of having one or more biological targets affinity bound to at least one capture species; detecting which capture species contain bound biological targets to generate a binding pattern; and identifying the biological target based on the binding pattern. The capture species are independently selected from the group consisting of antimicrobial peptides, cytotoxic peptides, antibiotics, and combinations thereof. A device having the capture species bound to the substrates. At least two of the capture species are capable of multi-specific binding to one or more biological targets and may have overlapping but not identical affinity properties.